2 Highly Ranked Stocks to Consider After Q2 Earnings: CLS, EXEL
Investors looking for a momentum stock that could be in store for higher highs may want to consider Celestica (CLS), while those looking for a buy-the-dip target have an intriguing option with Exelixis (EXEL).
Celestica Inc. (CLS) Q2 2025 Earnings Call Transcript
Celestica Inc. (NYSE:CLS ) Q2 2025 Earnings Conference Call July 29, 2025 8:00 AM ET Company Participants Mandeep Chawla - Chief Financial Officer Matthew P. - Corporate Participant Robert Andrew Mionis - President, CEO & Director Conference Call Participants Atif Malik - Citigroup Inc., Research Division David Vogt - UBS Investment Bank, Research Division Karl Ackerman - BNP Paribas Exane, Research Division Paul Michael Treiber - RBC Capital Markets, Research Division Robert Young - Canaccord Genuity Corp., Research Division Ruben Roy - Stifel, Nicolaus & Company, Incorporated, Research Division Samik Chatterjee - JPMorgan Chase & Co, Research Division Thanos Moschopoulos - BMO Capital Markets Equity Research Todd Adair Coupland - CIBC Capital Markets, Research Division Operator Ladies and gentlemen, thank you for joining us, and welcome to the Celestica Q2 2025 Financial Results and Conference Call.
Celestica: You Might Regret Going All In Now
AI-driven CapEx surges from big tech are fueling Celestica Inc.'s explosive growth, with a stellar beat-and-raise quarter driving the stock to new highs. Celestica's CCS segment is thriving due to robust hyperscaler demand and high-speed interconnectivity ramp-ups. Valuation is now extremely stretched, with CLS trading at over 24x forward EBITDA amidst significant customer concentration risk, warranting caution.
Celestica Beats Q2 Earnings Estimates on Solid Top-Line Growth
CLS tops Q2 estimates with 21% revenue growth and raises 2025 guidance, fueled by CCS demand and free cash flow strength.
Celestica Q2: Blowout Earnings Restore Bullish Case
Celestica Q2: Blowout Earnings Restore Bullish Case
Up 80% This Year What's Next For Celestica Stock?
Celestica (NYSE:CLS) has recently been experiencing significant growth — the stock has risen 80% year-to-date and has more than tripled in value over the past year. What factors are contributing to this increase?
Celestica (CLS) Q2 Earnings and Revenues Top Estimates
Celestica (CLS) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $0.91 per share a year ago.
Is Celestica (CLS) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Celestica (CLS) Stock Falls Amid Market Uptick: What Investors Need to Know
The latest trading day saw Celestica (CLS) settling at $163.98, representing a -2.85% change from its previous close.
Celestica (CLS) Just Flashed Golden Cross Signal: Do You Buy?
From a technical perspective, Celestica (CLS) is looking like an interesting pick, as it just reached a key level of support. CLS recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
CLS Stock Before Q2 Earnings: A Smart Buy or Risky Investment?
CLS eyes another earnings beat as AI demand and new product momentum drive strength in key growth segments.
3 Reasons Growth Investors Will Love Celestica (CLS)
Celestica (CLS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
